Zoetis Inc. Class A (ZTS)
ZTS · Health Care · 
United States
Zoetis Inc. Class A (ZTS) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 0.49%. Anyone who holds an ETF containing Zoetis also has an indirect stake in the company.
Data and Charts: Zoetis
Key Data for Zoetis
Zoetis Stock Price Chart
The Zoetis chart shows daily closing prices and is set to the current year by default. The stock is down 36.6% year to date and down 44.7% over twelve months. The last recorded close on October 30, 2026, was $79.72, at 14% of the 52-week range.
Price series from our database since Aug 12, 2024, 558 daily values.
Zoetis Stock Performance
| Year to date | -36.6% | 1 year | -44.7% |
|---|---|---|---|
| 1 month | +14.2% | 3 months | +3.1% |
| Calendar year 2025 | -22.8% |
Measured in euros, Zoetis is down 33.4% year to date and down 42.8% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Zoetis
What ETF Is Zoetis In?
Zoetis has above-average ETF coverage and is held by 22 of the 104 ETFs we track, which together follow 11 indices. That puts the stock in more ETFs than 85.1% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XUHL / XUHC | MSCI USA Health Care | 0.49% | €4.93 |
| XDWH | MSCI World Health Care | 0.36% | €3.64 |
| SPFS | MSCI World Health Care | 0.36% | €3.64 |
| XDEW | S&P 500 Equal Weight | 0.21% | €2.09 |
| 2B7K | MSCI World SRI | 0.15% | €1.50 |
| XDEQ | MSCI World Quality | 0.07% | €0.68 |
| SXR8 | S&P 500 | 0.05% | €0.50 |
| SPYL / SPY5 | S&P 500 | 0.05% | €0.50 |
| XD9U / XD9D | MSCI USA | 0.05% | €0.50 |
| SPYI / SPSA | MSCI ACWI IMI | 0.05% | €0.46 |
| EUNL | MSCI World | 0.04% | €0.40 |
| IUSQ | MSCI ACWI | 0.04% | €0.40 |
| SWWD | MSCI World | 0.04% | €0.37 |
| SPPW | MSCI World | 0.04% | €0.37 |
| XDWD / XDWL | MSCI World | 0.04% | €0.36 |
| WIMI | MSCI World IMI | 0.03% | €0.33 |
| SPYY | MSCI ACWI | 0.03% | €0.31 |
The last column shows how much of €1,000 in one of these funds goes to Zoetis, based on each fund's latest holdings list.
US-listed ETFs holding Zoetis (weight per latest SEC filing): VYM 0.13%, IVV 0.05%, SPY 0.05%, VOO 0.05%, VTI 0.04%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Zoetis Weight in iShares Core MSCI World (EUNL) Since 2019
In iShares Core MSCI World (EUNL), Zoetis had a weight of 0.14% on Sep 30, 2019 and 0.04% on Oct 30, 2026. The fund tracks the MSCI World. Its share peaked at 0.18% on Dec 31, 2021. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Zoetis overlaps with the rest of a portfolio.
Which Tracked Investors Hold Zoetis?
Zoetis is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. Of the 2 tracked managers holding the stock, 1 added and 1 cut.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Bridgewater Associates | 134,203 | $10M | increased by 83,464 |
| Soros Fund Management | 27,808 | $2M | reduced by 120,640 |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
Stocks With ETF Exposure Similar to Zoetis
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Zoetis | – | – | -44.7% | 31.4% | 28.2% | +2.3% |
 Waters Corporation | 22 | – | +34.9% | 37.1% | 20.3% | +7.0% |
| Agilent Technologies | 21 | – | +22.0% | 31.4% | 18.8% | +6.7% |
 IQVIA Holdings Inc | 21 | – | +23.5% | 38.6% | 8.3% | +5.9% |
 Mettler-Toledo International | 21 | – | +21.6% | 32.4% | 21.6% | +4.0% |
 Stryker Corporation | 21 | – | -20.9% | 25.8% | 12.9% | +11.2% |
 Veeva Systems | 21 | – | +9.8% | 38.7% | 28.4% | +16.3% |
 ResMed | 21 | – | -8.8% | 28.8% | 26.9% | +9.9% |
| STERIS | 21 | – | -3.8% | 23.8% | 13.2% | +8.7% |
These stocks reach a portfolio through largely the same funds as Zoetis. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: Zoetis
Zoetis Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 8.5 | 2.3 | 27.4% |
| FY ended Dec 2024 | 9.3 | 2.5 | 26.9% |
| FY ended Dec 2025 | 9.5 | 2.7 | 28.2% |
Technical Analysis: Zoetis
Zoetis Risk Metrics
The close on Oct 30, 2026, was 59.4% below the highest close since Aug 12, 2024. That high was reached on Sep 18, 2024. When the S&P 500 rose or fell 1%, Zoetis moved 0.48% on average in the same direction (past 252 trading days). The correlation of 0.16, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Zoetis.
What Zoetis Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| IDEXX Laboratories Inc. | +0.61 | |
| Boston Scientific Corporation | +0.54 | |
| Medtronic Plc | +0.53 | |
| Paychex Inc. | +0.53 | |
| Abbott Laboratories | +0.52 | |
| Fiserv Inc. | +0.51 | |
| Coherent Corp. | -0.56 | |
| Lumentum Holdings Inc. | -0.55 | |
| Rocket Lab Corporation | -0.50 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
